VanEck Healthcare TruSector ETF
VanEck Healthcare TruSector ETF reported 59 holdings worth US$833K as of Jun 30, 2026 (Form N-PORT)
As of Jun 30, 2026 ยท Filed Aug 26, 2026
VanEck Healthcare TruSector ETF reported 59 holdings worth US$833K as of Jun 30, 2026. Largest: Eli Lilly And Company, Johnson & Johnson and Abbvie Inc. Filed Aug 26, 2026 (Form N-PORT).
- Holdings
- 59
- Value as reported
- US$833K
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|
| Eli Lilly And Company | 115 | US$138K | 16.6% |
| Johnson & Johnson | 350 | US$88,890 | 10.7% |
| Abbvie Inc. | 257 | US$64,671 | 7.8% |
| Unitedhealth Group Incorporated | 132 | US$54,863 | 6.6% |
| Merck & Company, Inc. | 359 | US$46,132 | 5.5% |
| Amgen Inc. | 78 | US$28,245 | 3.4% |
| Thermo Fisher Scientific Inc | 54 | US$27,073 | 3.2% |
| Abbott Laboratories | 253 | US$22,957 | 2.8% |
| Gilead Sciences, Inc. | 181 | US$22,868 | 2.7% |
| Intuitive Surgical, Inc. | 52 | US$20,679 | 2.5% |
| Pfizer, Inc. | 829 | US$19,962 | 2.4% |
| Cvs Health Corporation | 186 | US$19,242 | 2.3% |
| Vertex Pharmaceuticals Incorporated | 37 | US$18,379 | 2.2% |
| Danaher Corporation | 92 | US$17,524 | 2.1% |
| Bristol-myers Squibb Company | 297 | US$17,113 | 2.1% |
| Stryker Corporation | 50 | US$15,742 | 1.9% |
| Medtronic Plc. | 187 | US$14,629 | 1.8% |
| Mckesson Corporation | 17 | US$12,845 | 1.5% |
| Elevance Health, Inc. | 32 | US$12,375 | 1.5% |
| The Cigna Group | 38 | US$10,476 | 1.3% |
| Regeneron Pharmaceuticals, Inc. | 15 | US$9,353 | 1.1% |
| Boston Scientific Corporation | 216 | US$9,219 | 1.1% |
| Hca Healthcare, Inc. | 23 | US$8,967 | 1.1% |
| Cardinal Health, Inc. | 34 | US$8,077 | 0.97% |
| Cencora, Inc. | 28 | US$7,923 | 0.95% |
| Edwards Lifesciences Corporation | 84 | US$7,599 | 0.91% |
| Humana Inc. | 17 | US$6,753 | 0.81% |
| Becton, Dickinson And Company | 40 | US$6,053 | 0.73% |
| Idexx Laboratories, Inc. | 11 | US$5,791 | 0.70% |
| Agilent Technologies, Inc. | 41 | US$5,446 | 0.65% |
| Waters Corporation | 14 | US$5,251 | 0.63% |
| Iqvia Holdings, Inc. | 24 | US$4,637 | 0.56% |
| Biogen Inc. | 21 | US$4,537 | 0.54% |
| Zoetis Inc. | 61 | US$4,383 | 0.53% |
| Centene Corporation | 68 | US$4,365 | 0.52% |
| Ge Healthcare Technologies Inc. | 66 | US$4,225 | 0.51% |
| Resmed Inc. | 21 | US$4,092 | 0.49% |
| Veeva Systems Inc. | 22 | US$3,904 | 0.47% |
| Mettler-toledo International, Inc. | 3 | US$3,833 | 0.46% |
| Dexcom, Inc. | 56 | US$3,772 | 0.45% |
| West Pharmaceutical Services, Inc. | 10 | US$3,590 | 0.43% |
| Moderna, Inc. | 51 | US$3,572 | 0.43% |
| Quest Diagnostics Incorporated | 16 | US$3,391 | 0.41% |
| Labcorp Holdings Inc. | 12 | US$3,360 | 0.40% |
| Steris Plc (ireland) | 14 | US$2,948 | 0.35% |
| Incyte Corporation | 24 | US$2,721 | 0.33% |
| Viatris Inc. | 169 | US$2,684 | 0.32% |
| Zimmer Biomet Holdings, Inc. | 28 | US$2,411 | 0.29% |
| The Cooper Companies, Inc. | 28 | US$2,008 | 0.24% |
| Revvity, Inc. | 16 | US$1,780 | 0.21% |
| Align Technology, Inc. | 10 | US$1,687 | 0.20% |
| Bio-techne Corp | 23 | US$1,625 | 0.20% |
| Solventum Corporation | 21 | US$1,620 | 0.19% |
| Baxter International Inc. | 75 | US$1,599 | 0.19% |
| Charles River Laboratories International, Inc. | 7 | US$1,588 | 0.19% |
| Insulet Corporation | 10 | US$1,523 | 0.18% |
| Universal Health Services, Inc. | 8 | US$1,190 | 0.14% |
| Henry Schein, Inc. | 14 | US$1,169 | 0.14% |
| Davita Inc. | 5 | US$1,112 | 0.13% |
Source
View original at SEC
Related